M. Alexander Otto, PA, MMS

Congenital CMV linked to pediatric hyperdiploid ALL

Publish date: January 18, 2023

Infection in some infants may alter immune function in a way that increases vulnerability to more direct causes of ALL.

Publish date: December 10, 2022

Study findings reveal “unacceptably low” access to HSCT in some regions, triggering a call to action.

Publish date: December 1, 2022

Doctor says real-world toxicity experience has been worse than clinical trial data.

Publish date: October 25, 2022

FDA has approved teclistamab as a new treatment option for heavily pretreated adults with relapsed/refractory multiple myeloma.

Publish date: October 24, 2022

“Patients who are taking aromatase inhibitors should try alternative strategies for management of genitourinary symptoms.”

Publish date: October 19, 2022

Acalabrutinib (Calquence) in tablet formulation approved by FDA.

Publish date: August 30, 2022

It is not covered by medical insurance, and is not approved by the Food and Drug Administration.